Oxycodone Use in Kidney Transplant Patients

Recommendations for Use in Kidney Transplant Patients

• The American Society of Clinical Oncology recommends considering more frequent clinical observation and dose adjustment in kidney transplant patients when using oxycodone 1
• The National Comprehensive Cancer Network recommends using short-acting opioid formulations initially to facilitate easier titration in kidney transplant patients 2

Safer Opioid Alternatives for Kidney Transplant Patients

• The American College of Clinical Pharmacy suggests that fentanyl is preferred for patients with renal impairment as it has no active metabolites and minimal renal clearance 1
• The European Renal Association considers buprenorphine one of the safest opioids for patients with kidney disease and can be administered at normal doses without adjustment due to its predominantly hepatic metabolism 3

Opioids to Avoid or Use with Extreme Caution

• The Mayo Clinic advises that morphine, codeine, and meperidine should be avoided in patients with renal impairment due to accumulation of potentially neurotoxic metabolites 2, 3, 4
• The National Kidney Foundation recommends that tramadol and tapentadol are not recommended in renal insufficiency (GFR <30 mL/min/1.73 m²) 3, 4

Monitoring and Management

• The American Pain Society recommends assessing pain using standardized scoring systems before and after administration in kidney transplant patients 1
• The American Society of Health-System Pharmacists suggests monitoring for signs of opioid toxicity including excessive sedation, respiratory depression, and hypotension in kidney transplant patients 1
• The Centers for Disease Control and Prevention advises having naloxone readily available to reverse severe respiratory depression if needed in kidney transplant patients 1